Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells.

by Félicie Cottard, Irène Asmane, Eva Erdmann, Jean-Pierre Bergerat, Jean-Emmanuel Kurtz, Jocelyn Céraline
Published 2013-01-01

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.

by Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean-Pierre Bergerat, Marie-France Poupon, Stéphane Oudard
Published 2012-01-01